

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 5.28574498 |
| 2 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.20255261 |
| 3 | NADH metabolic process (GO:0006734) | 5.09525259 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 4.99319652 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.85496151 |
| 6 | drug transport (GO:0015893) | 4.85007905 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.84004670 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.84004670 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.83993770 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.77866681 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 4.77866681 |
| 12 | urate metabolic process (GO:0046415) | 4.55183776 |
| 13 | glycolipid catabolic process (GO:0019377) | 4.52546019 |
| 14 | cysteine metabolic process (GO:0006534) | 4.43709463 |
| 15 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.39313578 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.38620076 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.38599905 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.38554495 |
| 19 | lysine metabolic process (GO:0006553) | 4.24629958 |
| 20 | lysine catabolic process (GO:0006554) | 4.24629958 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 4.21117541 |
| 22 | virion attachment to host cell (GO:0019062) | 4.19437666 |
| 23 | adhesion of symbiont to host cell (GO:0044650) | 4.19437666 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.18932828 |
| 25 | drug catabolic process (GO:0042737) | 4.18366371 |
| 26 | protein-lipid complex assembly (GO:0065005) | 4.03719160 |
| 27 | aldehyde catabolic process (GO:0046185) | 4.02704647 |
| 28 | tryptophan catabolic process (GO:0006569) | 4.02043770 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 4.02043770 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 4.02043770 |
| 31 | intestinal cholesterol absorption (GO:0030299) | 4.00045510 |
| 32 | homocysteine metabolic process (GO:0050667) | 3.92112568 |
| 33 | adhesion of symbiont to host (GO:0044406) | 3.85653466 |
| 34 | tryptophan metabolic process (GO:0006568) | 3.79841919 |
| 35 | modified amino acid transport (GO:0072337) | 3.79161377 |
| 36 | ceramide catabolic process (GO:0046514) | 3.77082877 |
| 37 | peptide catabolic process (GO:0043171) | 3.74569494 |
| 38 | intestinal absorption (GO:0050892) | 3.70554741 |
| 39 | lipoprotein transport (GO:0042953) | 3.66370879 |
| 40 | glycoside metabolic process (GO:0016137) | 3.66212516 |
| 41 | flavonoid metabolic process (GO:0009812) | 3.64504588 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 3.64345745 |
| 43 | sulfur amino acid catabolic process (GO:0000098) | 3.62609491 |
| 44 | fatty acid beta-oxidation (GO:0006635) | 3.53372688 |
| 45 | vitamin D metabolic process (GO:0042359) | 3.50083527 |
| 46 | angiotensin maturation (GO:0002003) | 3.49975830 |
| 47 | exogenous drug catabolic process (GO:0042738) | 3.47829385 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 3.47503619 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.47363159 |
| 50 | glucuronate metabolic process (GO:0019585) | 3.44293180 |
| 51 | uronic acid metabolic process (GO:0006063) | 3.44293180 |
| 52 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44172084 |
| 53 | sphingolipid catabolic process (GO:0030149) | 3.42699002 |
| 54 | folic acid transport (GO:0015884) | 3.42490890 |
| 55 | phospholipid efflux (GO:0033700) | 3.42003308 |
| 56 | bile acid metabolic process (GO:0008206) | 3.40757479 |
| 57 | oligosaccharide catabolic process (GO:0009313) | 3.38345016 |
| 58 | tricarboxylic acid metabolic process (GO:0072350) | 3.38043553 |
| 59 | organic cation transport (GO:0015695) | 3.36767493 |
| 60 | serine family amino acid biosynthetic process (GO:0009070) | 3.35126939 |
| 61 | branched-chain amino acid metabolic process (GO:0009081) | 3.34379211 |
| 62 | membrane lipid catabolic process (GO:0046466) | 3.33253622 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.32409439 |
| 64 | hormone catabolic process (GO:0042447) | 3.30217913 |
| 65 | fatty acid oxidation (GO:0019395) | 3.29909997 |
| 66 | kynurenine metabolic process (GO:0070189) | 3.29733161 |
| 67 | lipid oxidation (GO:0034440) | 3.27601955 |
| 68 | aromatic amino acid family metabolic process (GO:0009072) | 3.26796200 |
| 69 | proline metabolic process (GO:0006560) | 3.26745365 |
| 70 | cyclooxygenase pathway (GO:0019371) | 3.26075006 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.25344437 |
| 72 | fatty acid catabolic process (GO:0009062) | 3.24792432 |
| 73 | cellular glucuronidation (GO:0052695) | 3.24279760 |
| 74 | valine metabolic process (GO:0006573) | 3.24226920 |
| 75 | barbed-end actin filament capping (GO:0051016) | 3.24205648 |
| 76 | serine family amino acid catabolic process (GO:0009071) | 3.23524553 |
| 77 | branched-chain amino acid catabolic process (GO:0009083) | 3.23067306 |
| 78 | L-ascorbic acid metabolic process (GO:0019852) | 3.22242017 |
| 79 | bile acid biosynthetic process (GO:0006699) | 3.22236793 |
| 80 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.21341882 |
| 81 | drug metabolic process (GO:0017144) | 3.20239919 |
| 82 | daunorubicin metabolic process (GO:0044597) | 3.20230805 |
| 83 | polyketide metabolic process (GO:0030638) | 3.20230805 |
| 84 | doxorubicin metabolic process (GO:0044598) | 3.20230805 |
| 85 | vitamin biosynthetic process (GO:0009110) | 3.17903652 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 3.17660373 |
| 87 | negative regulation of sterol transport (GO:0032372) | 3.17660373 |
| 88 | regulation of triglyceride catabolic process (GO:0010896) | 3.16734960 |
| 89 | alpha-linolenic acid metabolic process (GO:0036109) | 3.15803994 |
| 90 | lipoprotein metabolic process (GO:0042157) | 3.15648713 |
| 91 | omega-hydroxylase P450 pathway (GO:0097267) | 3.14635993 |
| 92 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12730004 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.11953378 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.09624967 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.07226580 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.07226580 |
| 97 | glutathione derivative biosynthetic process (GO:1901687) | 3.07170061 |
| 98 | glutathione derivative metabolic process (GO:1901685) | 3.07170061 |
| 99 | glutathione metabolic process (GO:0006749) | 3.05524062 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.04306676 |
| 101 | fructose metabolic process (GO:0006000) | 3.03002429 |
| 102 | amyloid precursor protein catabolic process (GO:0042987) | 3.01975419 |
| 103 | alpha-amino acid catabolic process (GO:1901606) | 3.01236765 |
| 104 | amine catabolic process (GO:0009310) | 3.01143962 |
| 105 | cellular biogenic amine catabolic process (GO:0042402) | 3.01143962 |
| 106 | carnitine metabolic process (GO:0009437) | 3.00323674 |
| 107 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.99722787 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 2.97296319 |
| 109 | organic acid catabolic process (GO:0016054) | 2.96746155 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 2.96746155 |
| 111 | cellular amino acid catabolic process (GO:0009063) | 2.96734997 |
| 112 | complement activation, alternative pathway (GO:0006957) | 2.96383654 |
| 113 | reverse cholesterol transport (GO:0043691) | 2.95535242 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 2.95500541 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 2.94804781 |
| 116 | urea metabolic process (GO:0019627) | 2.94755717 |
| 117 | urea cycle (GO:0000050) | 2.94755717 |
| 118 | oxaloacetate metabolic process (GO:0006107) | 2.94750705 |
| 119 | plasma lipoprotein particle organization (GO:0071827) | 2.94633524 |
| 120 | xenobiotic catabolic process (GO:0042178) | 2.94255520 |
| 121 | response to mercury ion (GO:0046689) | 2.93153058 |
| 122 | diacylglycerol metabolic process (GO:0046339) | 2.92966840 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 2.92932874 |
| 124 | plasma lipoprotein particle assembly (GO:0034377) | 2.92526031 |
| 125 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.92302180 |
| 126 | protein carboxylation (GO:0018214) | 2.92302180 |
| 127 | plasma lipoprotein particle clearance (GO:0034381) | 2.92190118 |
| 128 | protein-lipid complex remodeling (GO:0034368) | 2.92053386 |
| 129 | macromolecular complex remodeling (GO:0034367) | 2.92053386 |
| 130 | plasma lipoprotein particle remodeling (GO:0034369) | 2.92053386 |
| 131 | cholesterol efflux (GO:0033344) | 2.91835698 |
| 132 | bile acid and bile salt transport (GO:0015721) | 2.91657144 |
| 133 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.89954197 |
| 134 | glutathione biosynthetic process (GO:0006750) | 2.89185790 |
| 135 | cholesterol homeostasis (GO:0042632) | 2.87909571 |
| 136 | regulation of sterol transport (GO:0032371) | 2.87494730 |
| 137 | regulation of cholesterol transport (GO:0032374) | 2.87494730 |
| 138 | ethanol oxidation (GO:0006069) | 2.85961243 |
| 139 | very long-chain fatty acid metabolic process (GO:0000038) | 2.85791158 |
| 140 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.85118737 |
| 141 | phenylpropanoid metabolic process (GO:0009698) | 2.84880164 |
| 142 | glucose 6-phosphate metabolic process (GO:0051156) | 2.81965937 |
| 143 | fibrinolysis (GO:0042730) | 2.78098226 |
| 144 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75235149 |
| 145 | sterol homeostasis (GO:0055092) | 2.72814404 |
| 146 | regulation of vitamin metabolic process (GO:0030656) | 2.71729516 |
| 147 | regulation of superoxide anion generation (GO:0032928) | 2.71008146 |
| 148 | glycosylceramide metabolic process (GO:0006677) | 2.65733343 |
| 149 | regulation of fibrinolysis (GO:0051917) | 2.65047866 |
| 150 | fat-soluble vitamin metabolic process (GO:0006775) | 2.62508464 |
| 151 | negative regulation of fibrinolysis (GO:0051918) | 2.61762304 |
| 152 | arachidonic acid metabolic process (GO:0019369) | 2.61606214 |
| 153 | negative regulation of blood coagulation (GO:0030195) | 2.60340930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.70630194 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84847265 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64606055 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.44203937 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.59397964 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56455980 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.28275287 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00598721 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.73086451 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72612320 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61854954 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.59583934 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33890079 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.18275768 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16023273 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15666061 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93890116 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84852782 |
| 19 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83349679 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.83097224 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79297758 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78597540 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77371748 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72832456 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68658787 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66440277 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63892538 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55037292 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54476066 |
| 30 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.53940259 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51873736 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48402762 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48254862 |
| 34 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46175439 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.45015756 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44068423 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43531896 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.41169954 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39188021 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38675621 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33806605 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28798377 |
| 43 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27764498 |
| 44 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.26735709 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26260752 |
| 46 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25565253 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25348760 |
| 48 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24836067 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24505343 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20509661 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18611935 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17035417 |
| 53 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16618978 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16508340 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16433489 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15931921 |
| 57 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15492808 |
| 58 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14944465 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14140052 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14125068 |
| 61 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13705228 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12665127 |
| 63 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12346511 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.11781997 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11562224 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10795556 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10554615 |
| 68 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09922200 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09189530 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07743237 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07496355 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06594551 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06567419 |
| 74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06145291 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05959229 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04899616 |
| 77 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.04897756 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04858669 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04122923 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03809952 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03535837 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01640968 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01170346 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00169564 |
| 85 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99804571 |
| 86 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97562840 |
| 87 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97120959 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97045465 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96986752 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96790288 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96470375 |
| 92 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95190026 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94976607 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94924662 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94810150 |
| 96 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94739740 |
| 97 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.94584250 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94520763 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93959122 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93703786 |
| 101 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93544094 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92661734 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92577496 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92333319 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91990344 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91372235 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90603570 |
| 108 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90098105 |
| 109 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88800353 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88209393 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88012646 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85432748 |
| 113 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.85161466 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84773479 |
| 115 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83753724 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83422950 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82598179 |
| 118 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.81677249 |
| 119 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.81614171 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81478692 |
| 121 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81457902 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81070292 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80587411 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80575180 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80516017 |
| 126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80397914 |
| 127 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78380552 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78171080 |
| 129 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.77814644 |
| 130 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76918065 |
| 131 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.76848964 |
| 132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76563308 |
| 133 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76516316 |
| 134 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76145407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.18726045 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.63519890 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.89087376 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.77140997 |
| 5 | MP0009840_abnormal_foam_cell | 3.76589866 |
| 6 | MP0005365_abnormal_bile_salt | 3.67298490 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.59735046 |
| 8 | MP0005332_abnormal_amino_acid | 3.12047082 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.09670437 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.06379598 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.82838469 |
| 12 | MP0003195_calcinosis | 2.82749740 |
| 13 | MP0003252_abnormal_bile_duct | 2.63910912 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.51236596 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.39127092 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.38992167 |
| 17 | MP0004043_abnormal_pH_regulation | 2.23286524 |
| 18 | MP0003186_abnormal_redox_activity | 2.06839343 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.05685983 |
| 20 | MP0003303_peritoneal_inflammation | 1.91584638 |
| 21 | MP0005083_abnormal_biliary_tract | 1.82793922 |
| 22 | MP0001764_abnormal_homeostasis | 1.77654678 |
| 23 | MP0005257_abnormal_intraocular_pressure | 1.74284577 |
| 24 | MP0001756_abnormal_urination | 1.71680652 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.70895732 |
| 26 | MP0005636_abnormal_mineral_homeostasis | 1.68609793 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.64001933 |
| 28 | MP0003868_abnormal_feces_composition | 1.58417447 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.58377079 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.57109495 |
| 31 | MP0000609_abnormal_liver_physiology | 1.56599733 |
| 32 | MP0002136_abnormal_kidney_physiology | 1.56585223 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.55984610 |
| 34 | MP0008260_abnormal_autophagy | 1.50395943 |
| 35 | MP0003436_decreased_susceptibility_to | 1.46722463 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44290926 |
| 37 | MP0005451_abnormal_body_composition | 1.41735692 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.36893620 |
| 39 | MP0005670_abnormal_white_adipose | 1.28978848 |
| 40 | MP0003329_amyloid_beta_deposits | 1.28268656 |
| 41 | MP0008469_abnormal_protein_level | 1.25510969 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.21998681 |
| 43 | MP0004147_increased_porphyrin_level | 1.21974511 |
| 44 | MP0000604_amyloidosis | 1.18101335 |
| 45 | MP0005409_darkened_coat_color | 1.16712378 |
| 46 | MP0002254_reproductive_system_inflammat | 1.13241505 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.12550552 |
| 48 | MP0006082_CNS_inflammation | 1.08263044 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.07508375 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.06666992 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.06556031 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.05725613 |
| 53 | MP0002419_abnormal_innate_immunity | 1.05286087 |
| 54 | MP0000538_abnormal_urinary_bladder | 1.03956340 |
| 55 | MP0003879_abnormal_hair_cell | 1.03115344 |
| 56 | MP0003724_increased_susceptibility_to | 1.02386895 |
| 57 | MP0002796_impaired_skin_barrier | 1.01318727 |
| 58 | MP0000598_abnormal_liver_morphology | 0.98541672 |
| 59 | MP0009785_altered_susceptibility_to | 0.98333738 |
| 60 | MP0003172_abnormal_lysosome_physiology | 0.98187185 |
| 61 | MP0000015_abnormal_ear_pigmentation | 0.98008088 |
| 62 | MP0001845_abnormal_inflammatory_respons | 0.94468859 |
| 63 | MP0005025_abnormal_response_to | 0.91935432 |
| 64 | MP0003878_abnormal_ear_physiology | 0.91593015 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 0.91593015 |
| 66 | MP0009764_decreased_sensitivity_to | 0.91347373 |
| 67 | MP0000858_altered_metastatic_potential | 0.88908497 |
| 68 | MP0002971_abnormal_brown_adipose | 0.88863746 |
| 69 | MP0009697_abnormal_copulation | 0.88697551 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.88642887 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.88603441 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 0.88529250 |
| 73 | MP0000372_irregular_coat_pigmentation | 0.88067104 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 0.86550940 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.83638679 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.83610393 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.81531454 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.81407162 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.81246501 |
| 80 | MP0000685_abnormal_immune_system | 0.79038778 |
| 81 | MP0009763_increased_sensitivity_to | 0.78431146 |
| 82 | MP0005000_abnormal_immune_tolerance | 0.77111470 |
| 83 | MP0004858_abnormal_nervous_system | 0.74667779 |
| 84 | MP0000920_abnormal_myelination | 0.74207807 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.73471286 |
| 86 | MP0001853_heart_inflammation | 0.72718661 |
| 87 | MP0002090_abnormal_vision | 0.72697125 |
| 88 | MP0001849_ear_inflammation | 0.72575342 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.70632301 |
| 90 | MP0002135_abnormal_kidney_morphology | 0.70107884 |
| 91 | MP0000490_abnormal_crypts_of | 0.69980691 |
| 92 | MP0003075_altered_response_to | 0.69930825 |
| 93 | MP0005023_abnormal_wound_healing | 0.69593645 |
| 94 | MP0006054_spinal_hemorrhage | 0.69010975 |
| 95 | MP0008004_abnormal_stomach_pH | 0.68605191 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.68234830 |
| 97 | MP0005408_hypopigmentation | 0.67635027 |
| 98 | MP0005266_abnormal_metabolism | 0.67213127 |
| 99 | MP0003690_abnormal_glial_cell | 0.66900906 |
| 100 | MP0001790_abnormal_immune_system | 0.66825269 |
| 101 | MP0005387_immune_system_phenotype | 0.66825269 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.66759748 |
| 103 | MP0003448_altered_tumor_morphology | 0.65809966 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.65473469 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.64980561 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.64815878 |
| 107 | MP0003866_abnormal_defecation | 0.64052905 |
| 108 | MP0000343_altered_response_to | 0.62753622 |
| 109 | MP0005535_abnormal_body_temperature | 0.62515728 |
| 110 | MP0009115_abnormal_fat_cell | 0.62325687 |
| 111 | MP0000249_abnormal_blood_vessel | 0.62194438 |
| 112 | MP0004947_skin_inflammation | 0.62113049 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.62101724 |
| 114 | MP0005165_increased_susceptibility_to | 0.61683630 |
| 115 | MP0005166_decreased_susceptibility_to | 0.59154925 |
| 116 | MP0002452_abnormal_antigen_presenting | 0.59015772 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.58906649 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.57497888 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.56844778 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.56335826 |
| 121 | MP0005501_abnormal_skin_physiology | 0.55557304 |
| 122 | MP0002723_abnormal_immune_serum | 0.54595847 |
| 123 | MP0005671_abnormal_response_to | 0.54154468 |
| 124 | MP0008873_increased_physiological_sensi | 0.53655667 |
| 125 | MP0003011_delayed_dark_adaptation | 0.53211135 |
| 126 | MP0001243_abnormal_dermal_layer | 0.52943667 |
| 127 | MP0001800_abnormal_humoral_immune | 0.52533516 |
| 128 | MP0003718_maternal_effect | 0.51881766 |
| 129 | MP0005395_other_phenotype | 0.51029948 |
| 130 | MP0005334_abnormal_fat_pad | 0.50510862 |
| 131 | MP0005448_abnormal_energy_balance | 0.50228783 |
| 132 | MP0001663_abnormal_digestive_system | 0.49945761 |
| 133 | MP0002405_respiratory_system_inflammati | 0.49048777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.93734876 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.93734876 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.93734876 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.53544110 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.33246629 |
| 6 | Hyperglycinuria (HP:0003108) | 4.19739060 |
| 7 | Proximal tubulopathy (HP:0000114) | 4.06959737 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.02738564 |
| 9 | Xanthomatosis (HP:0000991) | 3.85038956 |
| 10 | Generalized aminoaciduria (HP:0002909) | 3.76735351 |
| 11 | Gout (HP:0001997) | 3.72827618 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 3.72812386 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72812386 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.59193885 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.49891393 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.43977094 |
| 17 | Hyperammonemia (HP:0001987) | 3.43382704 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.43091996 |
| 19 | Glycosuria (HP:0003076) | 3.41409681 |
| 20 | Abnormality of urine glucose concentration (HP:0011016) | 3.41409681 |
| 21 | Loss of speech (HP:0002371) | 3.37861327 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.36781641 |
| 23 | * Systemic lupus erythematosus (HP:0002725) | 3.29884610 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 3.25055794 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.08240632 |
| 26 | Ketosis (HP:0001946) | 3.06642530 |
| 27 | Ketoacidosis (HP:0001993) | 3.06615591 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 3.02002164 |
| 29 | Hydroxyprolinuria (HP:0003080) | 3.02002164 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.01092112 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.98688148 |
| 32 | Complement deficiency (HP:0004431) | 2.96406301 |
| 33 | Vertebral compression fractures (HP:0002953) | 2.95390082 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 2.88616159 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 2.88609493 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88609493 |
| 37 | Fat malabsorption (HP:0002630) | 2.82815323 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81976296 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.69711359 |
| 40 | Glomerulonephritis (HP:0000099) | 2.69561577 |
| 41 | Hyperglycinemia (HP:0002154) | 2.68432314 |
| 42 | Hypokalemic alkalosis (HP:0001949) | 2.66192350 |
| 43 | Increased purine levels (HP:0004368) | 2.62870317 |
| 44 | Hyperuricemia (HP:0002149) | 2.62870317 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.62739231 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.62483401 |
| 47 | Hyperphosphaturia (HP:0003109) | 2.60647811 |
| 48 | Abnormality of complement system (HP:0005339) | 2.59638589 |
| 49 | Malnutrition (HP:0004395) | 2.59425007 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.56095662 |
| 51 | Vascular calcification (HP:0004934) | 2.51122273 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50431919 |
| 53 | Purpura (HP:0000979) | 2.49571387 |
| 54 | Nausea (HP:0002018) | 2.49159861 |
| 55 | Axonal loss (HP:0003447) | 2.48430415 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.48094547 |
| 57 | Lethargy (HP:0001254) | 2.46930184 |
| 58 | Progressive neurologic deterioration (HP:0002344) | 2.46396524 |
| 59 | Myocardial infarction (HP:0001658) | 2.46190915 |
| 60 | Metabolic acidosis (HP:0001942) | 2.43364987 |
| 61 | Abnormality of magnesium homeostasis (HP:0004921) | 2.42653451 |
| 62 | Hepatic necrosis (HP:0002605) | 2.42393732 |
| 63 | Ileus (HP:0002595) | 2.42162219 |
| 64 | Alkalosis (HP:0001948) | 2.41716298 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.40372601 |
| 66 | Vomiting (HP:0002013) | 2.36409320 |
| 67 | Abnormal urine output (HP:0012590) | 2.35941768 |
| 68 | Hypomagnesemia (HP:0002917) | 2.34911370 |
| 69 | Renal tubular acidosis (HP:0001947) | 2.34457909 |
| 70 | Abnormal urine phosphate concentration (HP:0012599) | 2.34306088 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.33533751 |
| 72 | Increased circulating renin level (HP:0000848) | 2.33108533 |
| 73 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.32554380 |
| 74 | Abnormality of renal excretion (HP:0011036) | 2.30532881 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29575931 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.29575931 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.29184650 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.25316195 |
| 79 | Cholecystitis (HP:0001082) | 2.25316195 |
| 80 | Hypoalphalipoproteinemia (HP:0003233) | 2.24541570 |
| 81 | Abnormality of methionine metabolism (HP:0010901) | 2.23089428 |
| 82 | Late onset (HP:0003584) | 2.22412960 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.22371447 |
| 84 | Hyperlipoproteinemia (HP:0010980) | 2.22348099 |
| 85 | Polyuria (HP:0000103) | 2.20549388 |
| 86 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.19763950 |
| 87 | Irritability (HP:0000737) | 2.18661206 |
| 88 | Pancreatitis (HP:0001733) | 2.18535860 |
| 89 | Joint hemorrhage (HP:0005261) | 2.17448837 |
| 90 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.15736888 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.15524992 |
| 92 | Nephrolithiasis (HP:0000787) | 2.15119637 |
| 93 | Hyperbilirubinemia (HP:0002904) | 2.14421587 |
| 94 | Methylmalonic aciduria (HP:0012120) | 2.14156088 |
| 95 | Rickets (HP:0002748) | 2.13258274 |
| 96 | Deep venous thrombosis (HP:0002625) | 2.12963540 |
| 97 | Abnormality of vitamin metabolism (HP:0100508) | 2.12895025 |
| 98 | Opisthotonus (HP:0002179) | 2.09597951 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.08885484 |
| 100 | Amyloidosis (HP:0011034) | 2.08852671 |
| 101 | Widely patent fontanelles and sutures (HP:0004492) | 2.08385563 |
| 102 | Abnormality of chloride homeostasis (HP:0011422) | 2.08257635 |
| 103 | Hypophosphatemia (HP:0002148) | 2.06740672 |
| 104 | Epidermoid cyst (HP:0200040) | 2.06528481 |
| 105 | Eczematoid dermatitis (HP:0000976) | 2.04604014 |
| 106 | Hypercholesterolemia (HP:0003124) | 2.01584094 |
| 107 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.00665467 |
| 108 | Abnormality of serum amino acid levels (HP:0003112) | 1.98815245 |
| 109 | Megaloblastic anemia (HP:0001889) | 1.98797397 |
| 110 | Steatorrhea (HP:0002570) | 1.98584870 |
| 111 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98557818 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98241850 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98241850 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98241850 |
| 115 | Mutism (HP:0002300) | 1.97950982 |
| 116 | Cerebral palsy (HP:0100021) | 1.97630489 |
| 117 | Elevated alkaline phosphatase (HP:0003155) | 1.97365008 |
| 118 | Renal tubular dysfunction (HP:0000124) | 1.97254621 |
| 119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96913924 |
| 120 | Increased serum ferritin (HP:0003281) | 1.96788185 |
| 121 | Nuclear cataract (HP:0100018) | 1.95711587 |
| 122 | Cerebral edema (HP:0002181) | 1.94465894 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94253993 |
| 124 | Nephritis (HP:0000123) | 1.93246622 |
| 125 | Abnormality of renal resorption (HP:0011038) | 1.92797569 |
| 126 | Bone pain (HP:0002653) | 1.91220515 |
| 127 | Paraparesis (HP:0002385) | 1.90072620 |
| 128 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89961783 |
| 129 | Retinal atrophy (HP:0001105) | 1.89005356 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.88235528 |
| 131 | Abdominal distention (HP:0003270) | 1.86999074 |
| 132 | Wide cranial sutures (HP:0010537) | 1.84747334 |
| 133 | Neurofibrillary tangles (HP:0002185) | 1.84552520 |
| 134 | Disinhibition (HP:0000734) | 1.83314166 |
| 135 | * Prolonged neonatal jaundice (HP:0006579) | 1.82789656 |
| 136 | Hepatosplenomegaly (HP:0001433) | 1.77723933 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.77336886 |
| 138 | Peripheral demyelination (HP:0011096) | 1.76378818 |
| 139 | Skin nodule (HP:0200036) | 1.75899178 |
| 140 | Multiple lipomas (HP:0001012) | 1.75760992 |
| 141 | Cardiomegaly (HP:0001640) | 1.74150524 |
| 142 | Gingival bleeding (HP:0000225) | 1.73990858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.07881476 |
| 2 | MST4 | 3.31343774 |
| 3 | WNK4 | 3.25086492 |
| 4 | ACVR1B | 3.01523443 |
| 5 | TGFBR2 | 2.80226044 |
| 6 | WNK3 | 2.78954818 |
| 7 | NME2 | 2.73148771 |
| 8 | ERN1 | 2.63751291 |
| 9 | RIPK1 | 2.62740239 |
| 10 | STK16 | 2.33403195 |
| 11 | OXSR1 | 2.33005229 |
| 12 | BLK | 2.32255462 |
| 13 | DDR2 | 2.08313085 |
| 14 | MAP3K14 | 1.96553497 |
| 15 | TYK2 | 1.93634055 |
| 16 | IRAK3 | 1.92915806 |
| 17 | TAOK2 | 1.89356619 |
| 18 | MAP2K2 | 1.86806979 |
| 19 | TESK2 | 1.86129944 |
| 20 | TBK1 | 1.84028850 |
| 21 | EPHA2 | 1.82814086 |
| 22 | FGFR4 | 1.77172431 |
| 23 | MST1R | 1.75663013 |
| 24 | GRK6 | 1.70515941 |
| 25 | ZAP70 | 1.69581137 |
| 26 | MAP4K1 | 1.65426274 |
| 27 | MAP3K3 | 1.63622841 |
| 28 | MAP2K3 | 1.63032280 |
| 29 | PIM2 | 1.59739555 |
| 30 | PRPF4B | 1.50610574 |
| 31 | MET | 1.47985747 |
| 32 | NME1 | 1.40889992 |
| 33 | MYLK | 1.36611323 |
| 34 | EIF2AK1 | 1.35014140 |
| 35 | EPHB1 | 1.34385790 |
| 36 | BUB1 | 1.30376852 |
| 37 | STK39 | 1.26253149 |
| 38 | MAP3K11 | 1.25579662 |
| 39 | PBK | 1.24405160 |
| 40 | TESK1 | 1.22961039 |
| 41 | MAP3K1 | 1.20821459 |
| 42 | STK38L | 1.19982481 |
| 43 | STK10 | 1.11447316 |
| 44 | BTK | 1.08409152 |
| 45 | CSF1R | 1.05713749 |
| 46 | PDK2 | 1.00949064 |
| 47 | TAOK1 | 0.99457783 |
| 48 | PAK4 | 0.98918256 |
| 49 | KDR | 0.95657165 |
| 50 | EPHB2 | 0.94981161 |
| 51 | LMTK2 | 0.93817033 |
| 52 | IRAK4 | 0.92032853 |
| 53 | GRK7 | 0.92010400 |
| 54 | EPHA3 | 0.91823800 |
| 55 | FRK | 0.91642566 |
| 56 | IKBKE | 0.90739569 |
| 57 | FGR | 0.87324683 |
| 58 | LRRK2 | 0.86246506 |
| 59 | PRKG2 | 0.85364069 |
| 60 | ABL2 | 0.83670935 |
| 61 | PDPK1 | 0.83478639 |
| 62 | IKBKB | 0.83437087 |
| 63 | CSK | 0.82200549 |
| 64 | TGFBR1 | 0.82066109 |
| 65 | ITK | 0.81747992 |
| 66 | DAPK1 | 0.81552724 |
| 67 | MAP2K6 | 0.81477408 |
| 68 | PIK3CG | 0.81117456 |
| 69 | SMG1 | 0.79852779 |
| 70 | PTK6 | 0.79416624 |
| 71 | FLT3 | 0.77422714 |
| 72 | PTK2 | 0.76873467 |
| 73 | CDC42BPA | 0.73466281 |
| 74 | MAP3K12 | 0.73087874 |
| 75 | EIF2AK3 | 0.71157761 |
| 76 | KIT | 0.68862833 |
| 77 | SCYL2 | 0.68105365 |
| 78 | PDGFRA | 0.66570046 |
| 79 | PRKCD | 0.65541221 |
| 80 | INSRR | 0.64497275 |
| 81 | MAPK11 | 0.63820474 |
| 82 | SYK | 0.63673018 |
| 83 | LYN | 0.63570824 |
| 84 | MAP3K8 | 0.62899010 |
| 85 | TXK | 0.61195968 |
| 86 | MAPK15 | 0.60926831 |
| 87 | CAMK2G | 0.60290568 |
| 88 | FER | 0.58892909 |
| 89 | ICK | 0.57954897 |
| 90 | DYRK1B | 0.57448167 |
| 91 | PDK3 | 0.53512212 |
| 92 | PDK4 | 0.53512212 |
| 93 | TAOK3 | 0.53436955 |
| 94 | LIMK1 | 0.52661854 |
| 95 | NEK1 | 0.52069581 |
| 96 | VRK2 | 0.52043620 |
| 97 | TRIB3 | 0.50918560 |
| 98 | ARAF | 0.50734418 |
| 99 | TEC | 0.50116260 |
| 100 | PAK1 | 0.49316843 |
| 101 | CDK19 | 0.49131382 |
| 102 | ERBB4 | 0.47832050 |
| 103 | TRPM7 | 0.47771958 |
| 104 | ILK | 0.46528872 |
| 105 | IRAK2 | 0.45761805 |
| 106 | PRKACG | 0.45647528 |
| 107 | JAK2 | 0.44538593 |
| 108 | MAPKAPK2 | 0.44415758 |
| 109 | LCK | 0.44019761 |
| 110 | GSK3A | 0.43799513 |
| 111 | SRC | 0.43454820 |
| 112 | PINK1 | 0.43048684 |
| 113 | TSSK6 | 0.42713240 |
| 114 | CDK6 | 0.42575860 |
| 115 | PIM1 | 0.41797120 |
| 116 | NEK9 | 0.41434799 |
| 117 | MAP3K5 | 0.40654172 |
| 118 | JAK1 | 0.40414512 |
| 119 | MAP2K1 | 0.40413095 |
| 120 | BMX | 0.39759186 |
| 121 | CSNK1G3 | 0.39078209 |
| 122 | CAMK2D | 0.38727987 |
| 123 | MAPKAPK3 | 0.38704486 |
| 124 | MOS | 0.37783112 |
| 125 | BRAF | 0.36103739 |
| 126 | CDK14 | 0.36043208 |
| 127 | JAK3 | 0.34756586 |
| 128 | PDK1 | 0.34406602 |
| 129 | DAPK3 | 0.32420799 |
| 130 | ADRBK2 | 0.32287142 |
| 131 | CDK11A | 0.32230877 |
| 132 | SIK1 | 0.31278887 |
| 133 | TIE1 | 0.31234336 |
| 134 | CHUK | 0.30440375 |
| 135 | MATK | 0.29319037 |
| 136 | PRKD1 | 0.28317871 |
| 137 | CDK15 | 0.27611576 |
| 138 | CDK9 | 0.26956097 |
| 139 | RPS6KA2 | 0.26403090 |
| 140 | PRKCA | 0.25541737 |
| 141 | AKT2 | 0.24758770 |
| 142 | PRKD3 | 0.24207774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93106562 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.65583477 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53417824 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44758425 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.28715143 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.19363505 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.16065883 |
| 8 | Peroxisome_Homo sapiens_hsa04146 | 2.14966434 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13234095 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11760555 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05640322 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.03541938 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.00002665 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97985496 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97923865 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.93190520 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91577074 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88046696 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87418576 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86187554 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.79399408 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68455812 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66974835 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64419198 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64398474 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64222157 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63186779 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62661008 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.62436896 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.57984835 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57311300 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53978991 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51266667 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50478240 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48751310 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48743375 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48100998 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46940835 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44832712 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38902836 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38010703 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37508169 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.37032065 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35323343 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33655466 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28766771 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27427681 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23200904 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18198997 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17037234 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15442967 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14902788 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13917225 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13533687 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12875164 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 1.12046158 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10443711 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07886897 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.06834017 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 1.04770728 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03997898 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00296074 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00266575 |
| 64 | Proteasome_Homo sapiens_hsa03050 | 0.99038710 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88662557 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85221688 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84999496 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83755986 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82513515 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82177144 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80907682 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77329730 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.73760612 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70287664 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68595632 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68286629 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.63793955 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63366187 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.57256423 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56493306 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55832865 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55072908 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54370551 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52545734 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51111989 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48694445 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.47702595 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.46033194 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40742537 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33709137 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.32548485 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.29030361 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.28921396 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28387918 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.28221775 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.28041458 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.26045916 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25926511 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25084650 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.24446011 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24314034 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20713416 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.18080532 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.12831539 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12757337 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.12253459 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11190835 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.10590717 |
| 109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.10466657 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.09549109 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09374378 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.09121243 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.08131960 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.07281505 |

